2-chloro-4-fluoro-1-(prop-2-ynloxy)benzene | 1249239-55-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2-chloro-4-fluoro-1-(prop-2-ynloxy)benzene
• 英文别名: 2-Chloro-4-fluoro-1-prop-2-ynoxybenzene
• CAS: 1249239-55-1
• 化学式: C₉H₆ClFO
• mdl: MFCD14631214
• 分子量: 184.597
• InChiKey: WZLSZEGSGJDGDF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.111
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-chloro-4-fluoro-1-(prop-2-ynloxy)benzene 、 5-azidomethyl-2-methylpyrimidine-4-ylamine 在 copper(ll) sulfate pentahydrate 、 sodium ascorbate 作用下， 以 水 、 叔丁醇 为溶剂， 生成 5-((4-((2-chloro-4-fluorophenoxy)methyl)-1H-1,2,3-triazol-1-yl)methyl)-2-methylpyrimidin-4-amine
  参考文献：
  名称：

  Design, synthesis and biological evaluation of novel 2-methylpyrimidine-4-ylamine derivatives as inhibitors of Escherichia coli pyruvate dehydrogenase complex E1

  摘要：

  As potential inhibitors of Escherichia coli pyruvate dehydrogenase complex E1 (PDHc E1), a series of novel 2-methylpyrimidine-4-ylamine derivatives were designed based on the structure of the active site of PDHc E1 and synthesized using 'click chemistry'. Their inhibitory activity in vitro against PDHc E1 and fungicidal activity were examined. Some of these compounds such as 3g, 3l, 3n, 3o, and 5b demonstrated to be effective inhibitors of PDHc E1 from E. coli and exhibited antifungal activity. SAR analysis indicated that both, the inhibitory potency against E. coli PDHc E1 and the antifungal activity of title compounds, could be increased greatly by optimizing substituent groups in the compounds. The structures of substituent group in 5-position on the 1,2,3-triazole and 4-position on the benzene ring in title compounds were found to play a pivotal role in both above-mentioned biological activities. Amongst all the compounds, compound 5b with iodine in the 5-position of 1,2,3-triazole and with nitryl group in the 4-position of benzene ring acted as the best inhibitor against PDHc E1 from E. coli. It was also found to be the most effective compound with higher antifungal activity against Rhizoctonia solani and Botrytis cinerea at the dosage of 100 mu g mL(-1). Therefore, in this study, compound 5b was used as a lead compound for further optimization. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2012.01.019
• 作为产物：
  描述：

  2-氯-4-氟苯酚 、 3-溴丙炔 在 potassium carbonate 作用下， 以 丙酮 为溶剂， 反应 4.0h， 生成 2-chloro-4-fluoro-1-(prop-2-ynloxy)benzene
  参考文献：
  名称：

  甘露糖末端配体的合成和血凝抑制特性：末端苯基和甘露糖残基与三唑部分之间的接头的作用

  摘要：

  通过 Cu(I) 催化的叠氮化物-炔烃环加成反应 (CuAAC) 可以很容易地组装来自具有反向连接功能的d-甘露糖的两个三唑缀合物家族 (A, B )。甘露糖前体由 3-叠氮丙基或炔丙基糖苷配基构成，而苯基部分分别由末端叠氮基或炔丙基构成。在血凝抑制 (HAI) 试验中，A 族 ( 7a - 11a )，其中甘露糖残基和三唑环之间的接头是三个碳原子，与 B 族 ( 13a - 17a )相比，其活性增强了 3-5 倍。甲基-三唑基部分。代表配体7a，其中末端苯环被酯基取代，Cl 原子表现出最高的抑制活性，HAI 滴度为 8 μM。该化合物可能是进一步设计针对 FimH 菌毛凝集素的有效甘露糖基配体的良好候选者。

  DOI：

  10.1016/j.carres.2022.108559

文献信息

• [EN] HISTONE DEMENTHYLASE INHIBITORS<br/>[FR] INHIBITEURS D'HISTONE DÉMÉTHYLASE
  申请人：QUANTICEL PHARMACEUTICALS INC

  公开号：WO2014164708A1

  公开（公告）日：2014-10-09

  The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyrrolopyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

  本发明一般涉及治疗癌症和肿瘤性疾病的组合物和方法。本文提供了替代吡咯吡啶衍生物化合物和包含该化合物的药物组合物。所述化合物和组合物对组蛋白去甲基化酶的抑制具有用处。此外，所述化合物和组合物对癌症的治疗具有用处，如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等。
• HISTONE DEMETHYLASE INHIBITORS
  申请人：QUANTICEL PHARMACEUTICALS, INC.

  公开号：US20160194315A1

  公开（公告）日：2016-07-07

  The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyrrolopyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

  本发明涉及治疗癌症和肿瘤疾病的组合物和方法。本发明提供了取代吡咯吡啶衍生物化合物和含有该化合物的制药组合物。所述化合物和组合物可用于抑制组蛋白去甲基化酶。此外，所述化合物和组合物可用于治疗癌症，如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等。
• Histone demethylase inhibitors
  申请人：CELGENE QUANTICEL RESEARCH, INC.

  公开号：US10174026B2

  公开（公告）日：2019-01-08

  The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyrrolopyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

  本发明一般涉及治疗癌症和肿瘤性疾病的组合物和方法。本发明提供了取代的吡咯并吡啶衍生物化合物和包含所述化合物的药物组合物。所述化合物和组合物可用于抑制组蛋白去甲基化酶。此外，所述化合物和组合物还可用于治疗癌症，如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等。
• HISTONE DEMENTHYLASE INHIBITORS
  申请人：Celgene Quanticel Research, Inc.

  公开号：EP2968282B1

  公开（公告）日：2018-05-09
• NITRIFICATION INHIBITORS
  申请人：BASF SE

  公开号：US20170036969A1

  公开（公告）日：2017-02-09

  The present invention relates to novel nitrification inhibitors of formula I. Moreover, the invention relates to the use of these novel nitrification inhibitors for reducing nitrification, as well as agrochemical mixtures and compositions comprising the nitrification inhibitors. Further encompassed by the present invention are methods for reducing nitrification comprising the treatment of plants, soil and/or loci with said nitrification inhibitors, and methods for treating a fertilizer or a composition by applying said nitrification inhibitor.